Allosteric modulation of the 5-HT(3) receptor.

Allosteric modulation of the 5-HT(3) receptor.
复制标题

DOI:
10.1016/j.coph.2011.01.010
复制
发表时间:
2011-02
影响因子:
4
通讯作者:
Davies, Paul A.
Davies, Paul A.
中科院分区:
医学3区
文献类型:
--
作者:
Davies, Paul A.

文献摘要

参考文献

被引文献

相似文献

5-羟色胺3型(5-HT 3)受体是配体门控离子通道,其在抑郁、焦虑、物质滥用、呕吐、炎性疼痛、脊髓伤害感受、胃肠功能和心血管反射中发挥重要作用。可能研究最多的5-HT 3受体调节剂是以昂丹司琼为代表的高亲和力竞争性“司琼”拮抗剂。然而,存在广泛的化合物调节5-HT 3受体,不是通过正构位点,而是通过结合到变构位点。最值得注意的是归因于某些靶点但在临床相关浓度下变构调节5-HT 3受体的治疗性化合物。
5-Hydroxytryptamine type 3 (5-HT3) receptors are ligand-gated ion channels that play important roles in depression, anxiety, substance abuse, emesis, inflammatory pain, spinal nociception, gastrointestinal function, and cardiovascular reflexes. Probably the most studied modulators of 5-HT3 receptors are the high affinity competitive ‘setron’ antagonists typified by ondansetron. However, there exists a broad range of compounds that modulate the 5-HT3 receptor, not through the orthosteric site but by binding to allosteric sites. Most notable are therapeutic compounds ascribed to certain targets but that allosterically modulate 5-HT3 receptors at clinically relevant concentrations.
DOI: 10.1124/jpet.109.164863
发表时间: 2010-06-01
影响因子: 3.5
作者:
Feinberg-Zadek, Paula L.;Davies, Paul A.
通讯作者: Davies, Paul A.
DOI: 10.1016/j.molbraines.2005.09.011
发表时间: 2005-12-14
期刊: MOLECULAR BRAIN RESEARCH
影响因子: --
作者:
Hayrapetyan, V;Jenschke, M;Machu, TK
通讯作者: Machu, TK
DOI: 10.1213/01.ane.0000050769.34933.03
发表时间: 2003-04-01
影响因子: 5.7
作者:
Koshizaki, M;Kawamata, M;Collins, JG
通讯作者: Collins, JG
DOI: 10.1097/fpc.0b013e3282f51092
发表时间: 2008-03-01
影响因子: 2.6
作者:
Meineke, Cornelia;Tzvetkov, Mladen Vassilev;Brockmoeller, Juergen
通讯作者: Brockmoeller, Juergen
DOI: 10.1111/j.1476-5381.1994.tb13140.x
发表时间: 1994-07-01
影响因子: 7.3
作者:
FAN, P
通讯作者: FAN, P